TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 82 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $739,000 | -54.6% | 6,558 | -54.9% | 0.00% | 0.0% |
| Q2 2017 | $1,629,000 | +4.3% | 14,538 | +8.5% | 0.00% | 0.0% |
| Q1 2017 | $1,562,000 | +61.7% | 13,394 | +46.0% | 0.00% | 0.0% |
| Q4 2016 | $966,000 | +62.4% | 9,172 | +70.3% | 0.00% | 0.0% |
| Q3 2016 | $595,000 | -21.3% | 5,385 | +3.8% | 0.00% | 0.0% |
| Q2 2016 | $756,000 | -92.0% | 5,190 | -92.1% | 0.00% | -87.5% |
| Q1 2016 | $9,453,000 | +104.0% | 65,991 | +120.1% | 0.01% | +100.0% |
| Q4 2015 | $4,634,000 | +17.7% | 29,981 | +8.8% | 0.00% | +33.3% |
| Q3 2015 | $3,938,000 | -0.6% | 27,560 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $3,960,000 | +1.9% | 27,560 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $3,887,000 | +25.5% | 27,560 | +31.9% | 0.00% | 0.0% |
| Q4 2014 | $3,096,000 | +226.6% | 20,890 | +239.1% | 0.00% | +200.0% |
| Q3 2014 | $948,000 | +13442.9% | 6,160 | +10340.7% | 0.00% | – |
| Q1 2014 | $7,000 | +250.0% | 59 | +195.0% | 0.00% | – |
| Q4 2013 | $2,000 | 0.0% | 20 | 0.0% | 0.00% | – |
| Q3 2013 | $2,000 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Claret Asset Management Corp | 86,474 | $6,524,000 | 1.34% |
| Analyst IMS Investment Management Services Ltd. | 28,438 | $2,143,000 | 0.64% |
| ALGERT GLOBAL LLC | 20,876 | $1,575,000 | 0.59% |
| Quantinno Capital Management LP | 9,351 | $706,000 | 0.48% |
| Crestline Management, LP | 37,000 | $2,792,000 | 0.45% |
| Empirical Finance, LLC | 9,561 | $721,000 | 0.20% |
| BRANDES INVESTMENT PARTNERS, LP | 55,065 | $5,469,000 | 0.14% |
| FORT, L.P. | 9,672 | $730,000 | 0.14% |
| CAXTON ASSOCIATES LP | 8,865 | $669,000 | 0.13% |
| ACADIAN ASSET MANAGEMENT LLC | 330,448 | $24,928,000 | 0.11% |